Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00840372
Other study ID # Needles
Secondary ID Semi-blunt needl
Status Completed
Phase N/A
First received February 9, 2009
Last updated September 28, 2009
Start date November 2008
Est. completion date March 2009

Study information

Verified date September 2009
Source Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Contact n/a
Is FDA regulated No
Health authority Belgium: Institutional Review Board
Study type Observational

Clinical Trial Summary

The aim of this observational study in patients chronically hemodialyzed by a native arterio-venous fistula is to determine the impact of the use of semi-blunt needles on the quality of the punction. The investigators have observed that cannulation with blunt needles (button-hole method) is sometimes difficult and the use of a sharp needle may be necessary, with consequently more hematomes and infections. Our hypothesis is that canulation with semi-blunt needles would be easier than with classical blunt needles, and consequently the use of sharp needles would become less frequent.

Inclusion criteria and study design are detailed below.


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date March 2009
Est. primary completion date March 2009
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Chronic hemodialysis patients

- Aged 18 years or more

- Dialyzed by a native arterio-venous fistula

- Cannuled by buttonhole method with blunt needles

Exclusion Criteria:

- Acute hemodialysis

- Puncture with 14G needles

- Puncture with a sole needle

- Arterio-venous grafts

- Patients transferred from another centre

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Procedure:
Buttonhole cannulation with semi-blunt needles
Use of semi-blunt needles, compared to blunt needles, at every dialysis session

Locations

Country Name City State
Belgium Cliniques Universitaires Saint Luc Brussels

Sponsors (1)

Lead Sponsor Collaborator
Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Primary Incidence of AVF hematomes Two months No
Primary Incidence of use of sharp needles Two months No
Secondary Incidence of trampoline-effect Two months No
Secondary Incidence of AVF infections Two months No
See also
  Status Clinical Trial Phase
Recruiting NCT04420338 - SeroCOVIDial Study: Assessment of COVID-19 Seroconversion in Patients on Chronic Hemodialysis and in Their Caregivers, a Cohort Study N/A
Not yet recruiting NCT05410275 - Chronic Anticoagulation With a Reduced Dose Regimen of Rivaroxaban in End-stage Renal Disease Patients Phase 3